Kadia TM, Reville PK, Wang X, Rausch CR, et al. Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. J Clin Oncol 2022 Jun 15:JCO2102823. doi: 10.1200/JCO.21.02823.
PMID: 35704787